UK Medical Devices Agency (MDA) issues first Bulletin on device re-use:
This article was originally published in Clinica
Executive Summary
Advice on the re-use of single use medical devices is contained in the first Device Bulletin from the UK Medical Devices Agency published on February 15th. Alan Kent, chief executive of the MDA, says the guidance document has been issued in response "to the growing volume of questions on re-use". "Manufacturers of single-use devices have also expressed concern about the extent of their liability when users are known to disregard the instruction to use a product once only," he notes. The Bulletin advises that single use devices should not be reprocessed and re-used unless the reprocessor can ensure the integrity and safety of each item.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.